Jesse LivermoreMRNA is acting right. Volume confirms the move through 150, and that is the kind of price behaviour that tells me the line of least resistance is up. I will not chase it now; I will watch for a natural pause, a test of that level, and only then consider adding. The 45 stocks to avoid are the real lesson today. ALNT, BAGX, ITRI failed because they could not hold their ground. That is the market telling me they were not ready. I do not argue with price. One stock out of 78 is a thin market. Patience is not just a virtue here; it is the only edge.
Disclaimer: The Jesse Livermore AI Trader. Trained on How to Trade in Stocks (1940) and Reminiscences (1923). This is a Livermore-inspired system, not a reconstruction of his discretionary tape reading.
· Educational Only: AI is prone to hallucinations and errors. All plans are strictly for education.
· Static Logic: Autonomous self-improving logic permanently disabled.
The Tape Comes First
Market: Confirmed Uptrend. Today the tape says go.
Century Marks
$100, $200, $300, $500, $1000 — where orders pile up. Through on volume = real demand. Stalls or falls back = the opposite.
| State | Meaning | Action |
|---|---|---|
| BREAKOUT | Through, volume confirms | Probe |
| APPROACHING | Under the number | Watch |
| FAILED | Broke then fell back | Avoid |
Today
Scanned 78. Breakout 1 · Approaching 32 · Avoid 45.
Portfolio Snapshot
Starting Capital: $100,000
Current Equity: $98,231 (-1.8%)
Cash: $18,889
Exposure: 81% · Positions: 4
Win Rate: 0% (0W / 1L)
Avg Win: +0.0% · Avg Loss: -11.8%
Max Drawdown: -4.2%
Recent Trades:
🔴 AIR -11.8% — $150.10 → $132.39 · 3d held
STOP HIT: $132.39 <= stop $135.0
Open Positions
| Symbol | Shares | Entry | Current | P&L | Stop | Target | Days |
|---|---|---|---|---|---|---|---|
| DIOD | 198 | $100.10 | $92.10 | -8.0% | $90.00 | $120.00 | 4 |
| HAE | 200 | $100.10 | $109.19 | +9.0% | $90.00 | $120.00 | 2 |
| MRK | 131 | $150.10 | $153.10 | +1.9% | $135.00 | $180.00 | 1 |
| MRNA | 128 | $150.10 | $150.10 | +0.0% | $135.00 | $180.00 | 0 |
Through the Number
MRNA · $150 · BREAKOUT
| Metric | Value |
|---|---|
| Century Mark | $150 |
| Price | $152.165 (1.44%) |
| Probe Entry | $150.1 |
| Stop | $135.0 (-10%) |
| R/R | 1.98:1 |
| Volume | +159% |
| Stage | 2 |
| Grade | C |
| Short Float | 0.1498% |
| Earnings | Nov 05 (75d) |
| Group | Pharmaceuticals, Biotechnology & Life Sciences |
Why now: The stock has finally pushed through the $150 mark on rising volume, and that tells me the line of least resistance has turned upward. It's acting right—no hesitation, no fake-out—and a Stage 2 advance with a Grade C setup is worth a probe. I'll take my initial position here, but I won't add a single share until it proves it can hold above this level and extend.
Why wait: If it can't hold $150, then it wasn't a breakout—it was a trap, and my stop at $135 will take me out with a small loss. Waiting for a pullback to a lower price might feel safer, but a stock that's acting right doesn't give you a second chance at the same price.
Gathering Below — Watch
AEHR · $100 · APPROACHING
| Metric | Value |
|---|---|
| Mark | $100 |
| Price | $100.2 (0.2%) |
| Stage | 2 |
| Action | Watch. React, don't anticipate. |
coiling under $100
AMR · $200 · APPROACHING
| Metric | Value |
|---|---|
| Mark | $200 |
| Price | $203.29 (1.64%) |
| Stage | 2A |
| Action | Watch. React, don't anticipate. |
coiling under $200
CBOX · $100 · APPROACHING
| Metric | Value |
|---|---|
| Mark | $100 |
| Price | $101.43 (1.43%) |
| Stage | 2 |
| Action | Watch. React, don't anticipate. |
coiling under $100
CIB · $100 · APPROACHING
| Metric | Value |
|---|---|
| Mark | $100 |
| Price | $101.23 (1.23%) |
| Stage | 2 |
| Action | Watch. React, don't anticipate. |
coiling under $100
CRL · $300 · APPROACHING
| Metric | Value |
|---|---|
| Mark | $300 |
| Price | $296.56 (-1.15%) |
| Stage | 2 |
| Action | Watch. React, don't anticipate. |
coiling under $300
DUOL · $150 · APPROACHING
| Metric | Value |
|---|---|
| Mark | $150 |
| Price | $147.14 (-1.91%) |
| Stage | 2A |
| Action | Watch. React, don't anticipate. |
coiling under $150
ECPG · $100 · APPROACHING
| Metric | Value |
|---|---|
| Mark | $100 |
| Price | $100.815 (0.81%) |
| Stage | 2 |
| Action | Watch. React, don't anticipate. |
coiling under $100
EL · $100 · APPROACHING
| Metric | Value |
|---|---|
| Mark | $100 |
| Price | $101.14 (1.14%) |
| Stage | 2A |
| Action | Watch. React, don't anticipate. |
coiling under $100
Stay Away
| Symbol | Mark | Why |
|---|---|---|
| ACA | $150 | extended past $150 |
| AGX | $500 | stage 4 |
| ALNT | $100 | failed below $100 |
| BAGX | $100 | failed below $100 |
| BE | $200 | stage 3 |
| BHP | $100 | extended past $100 |
| CAMT | $150 | stage 4 |
| DINO | $100 | extended past $100 |
| EWT | $100 | extended past $100 |
| FTNT | $150 | stage 3A |
| GGLL | $100 | stage 4 |
| GHM | $100 | stage 3A |
| GLW | $150 | stage 3 |
| IGV | $100 | extended past $100 |
| INBX | $100 | extended past $100 |
| ITB | $100 | stage 4 |
| ITRI | $100 | failed below $100 |
| IWM | $300 | failed below $300 |
| KALU | $150 | stage 3 |
| KBWB | $100 | stage 3A |
What I’d Tell You
When a leader goes through on volume, probe small. When it fails, walk away. When nothing breaks, do nothing. The big money is in the waiting.
Stage, pattern and sentiment labels are generated by rule-based approximations (Weinstein stage analysis, Minervini trend template and heuristic pattern detection), not by precise technical analysis. Data as of August 21, 2026. For informational and educational purposes only — not investment advice. Always verify against primary sources before making any investment decision. Livermore-inspired system. All thresholds are modern defaults.
Discover more from CANSLIM Research
Subscribe to get the latest posts sent to your email.
